Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - NET INCOME
Net Income EBS - Emergent BioSolutions Inc.
-760 M
LAST VALUE
-107.21%
2 YEAR CAGR
-67.36%
5 YEAR CAGR
-38.59%
10 YEAR CAGR